November 18, 2025 
The Manager- Listing 
BSE Limited 
Corporate Relationship Dept., 5th Floor, New Trading Ring 
Rotunda Building, P J Towers, Dalal Street, Fort,  
Mumbai – 400 001  
The Manager- Listing 
National Stock Exchange of India Limited 
Exchange Plaza, 5th Floor, Plot No. C/1, G - Block 
Bandra –Kurla Complex, Bandra (E),  
Mumbai – 400 051 
Dear Sir(s), 
Sub:  Information pursuant to Regulation 3 0 of SEBI (Listing Obligations and Disclosure 
Requirements) Regulations, 2015 
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 
2015, we would like to inform that Dr. Ajay Sharma , currently the Director – Corporate Affairs at 
AstraZeneca Pharma India Limited  (‘the Company’)  has decided to pursue his career outside the 
organization. He will complete his handover period by close of business hours on November 26, 2025. 
The Company is looking for a suitable replacement for the said position. We wish Dr. Ajay Sharma all 
the best in his future endeavors. 
The information as required under the  SEBI circular SEBI/HO/CFD/PoD2/CIR/P/0155 dated 
November 11, 2024, along-with a copy of the resignation letter is enclosed. 
Kindly take the above information on record. 
For AstraZeneca Pharma India Limited 
Manasa. R 
Company Secretary 
 
 
Annexure - A 
Sl. No Particulars Details 
1.  Reason for change  Resignation of Dr. Ajay Sharma , Director – Corporate Affairs 
to pursue his career outside the Company 
2.  Date of cessation  Effective close of business hours on November 26, 2025 
3.  Term of appointment Not applicable 
4.  Brief Profile Not applicable 
5.  Disclosure of relationships 
between directors (in case of 
appointment of director) 
 
Not Applicable 
 
 
